Analysts at Piper Jaffray set a $28.00 price objective on shares of BioDelivery Sciences International (NASDAQ:BDSI) stock in a research report issued to clients and investors on Tuesday. The firm currently has a “buy” rating on the stock. Piper Jaffray’s target price suggests a potential upside of 125.44% from the stock’s previous close. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) belongs to Healthcare sector. Its weekly performance … Continue reading Stocks Swings: BioDelivery Sciences International, Inc. (NASDAQ:BDSICountry Style Cooking Restaurant Chain (NYSE:CCSC), BB&T Corporation (NYSE:BBT), Microsoft (NASDAQ:MSFT), Express Scripts (NASDAQ:ESRX)